Obesity, a growing global epidemic, is identified as a significant, modifiable risk factor for ovarian cancer, a deadly gynecologic malignancy often diagnosed late. Research indicates that increased ...

2025 ASCO Presentation: Innovent Biologics Announces Updated Data of IBI354 (Novel anti-HER2 ADC) From the Phase 1/2 Clinical Study in Advanced Ovarian Cancer, Breast Cancer and Other Solid Tumors ...

Ovarian cancer has earned the terrifying nickname “the silent killer” because it’s notorious for causing vague, easily dismissed symptoms that women often attribute to stress, aging, or ...

TAMPA, Fla. — A new study of a cancer treatment called HIPEC, heated intraperitoneal chemotherapy, is showing good results when it comes to treating women with metastatic epithelial ovarian ...

Ovarian cancer is one of the most lethal cancer affecting females. According to GLOBOCAN 2020 statistics, 1.6% of new cases and 2.1% of deaths of all sites are attributable to ovarian cancer. It ...

By analyzing the contents of ascites fluid from ovarian cancer patients, they identified a group of fat molecules called phospholipids as key drivers of this immune dysfunction, suggesting that ...

New research has uncovered how lipid-rich fluid in the abdomen, known as ascites, plays a central role in weakening the body's immune response in advanced ovarian cancer. The findings offer new ...

Ovarian Cancer Warning Symptoms: Unexplained weight gain, to frequent urination - Never ignore these 7 warning signs and symptoms of ovarian cancer in your 30s. TheHealthSite.com ...

World Ovarian Cancer Day, observed on May 8, highlights this deadly cancer affecting women globally. Often difficult to detect due to subtle symptoms mimicking other conditions, it's crucial to ...

Every year on May 8, World Ovarian Cancer Day is observed. It aims to increase awareness about ovarian cancer. Ovarian cancer is among the most underdiagnosed cancers in females. It is also known ...

As we approach World Ovarian Cancer Day on May 8th, a global moment to raise our voices and awareness. It's the perfect time to explore how innovation is truly revolutionising treatment.

A common blood test for ovarian cancer is more likely to fall short for Black and Native American women, according to a new study. This was the case for Nefa-Tari Moore, 45, a three time "thriver ...